Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
4.013
+0.103 (2.62%)
Nov 21, 2024, 4:00 PM EST - Market closed
Xenetic Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 6.84 | 8.98 | 13.1 | 18.24 | 11.53 | 10.37 | Upgrade
|
| Cash & Short-Term Investments | 6.84 | 8.98 | 13.1 | 18.24 | 11.53 | 10.37 | Upgrade
|
| Cash Growth | -30.04% | -31.41% | -28.21% | 58.26% | 11.18% | 1713.83% | Upgrade
|
| Prepaid Expenses | 0.19 | 0.6 | 0.56 | 0.25 | 0.84 | 0.72 | Upgrade
|
| Other Current Assets | - | - | - | 0.23 | - | - | Upgrade
|
| Total Current Assets | 7.03 | 9.59 | 13.65 | 18.72 | 12.37 | 11.09 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.03 | 0 | Upgrade
|
| Other Intangible Assets | - | - | - | - | - | 9.24 | Upgrade
|
| Other Long-Term Assets | 1.02 | 1.02 | 0.67 | 0.69 | 0.68 | 1.21 | Upgrade
|
| Total Assets | 8.05 | 10.61 | 14.72 | 19.82 | 13.18 | 21.55 | Upgrade
|
| Accounts Payable | 0.24 | 0.24 | 0.29 | 0.36 | 0.33 | 0.93 | Upgrade
|
| Accrued Expenses | 0.77 | 0.57 | 0.79 | 1.03 | 0.57 | 0.46 | Upgrade
|
| Current Portion of Leases | - | - | - | 0.03 | 0.04 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | - | 0.02 | Upgrade
|
| Total Current Liabilities | 1.01 | 0.81 | 1.07 | 1.42 | 0.94 | 1.42 | Upgrade
|
| Long-Term Leases | - | - | - | - | 0.03 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 2.92 | Upgrade
|
| Total Liabilities | 1.01 | 0.81 | 1.07 | 1.42 | 0.96 | 4.33 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 208.2 | 208.05 | 207.77 | 205.95 | 194.13 | 188.24 | Upgrade
|
| Retained Earnings | -196.14 | -193.23 | -189.1 | -182.55 | -176.9 | -166.01 | Upgrade
|
| Treasury Stock | -5.28 | -5.28 | -5.28 | -5.28 | -5.28 | -5.28 | Upgrade
|
| Comprehensive Income & Other | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | Upgrade
|
| Total Common Equity | 7.03 | 9.79 | 13.64 | 18.39 | 12.21 | 17.21 | Upgrade
|
| Shareholders' Equity | 7.04 | 9.8 | 13.65 | 18.39 | 12.22 | 17.21 | Upgrade
|
| Total Liabilities & Equity | 8.05 | 10.61 | 14.72 | 19.82 | 13.18 | 21.55 | Upgrade
|
| Total Debt | - | - | - | 0.03 | 0.06 | - | Upgrade
|
| Net Cash (Debt) | 6.84 | 8.98 | 13.1 | 18.22 | 11.47 | 10.37 | Upgrade
|
| Net Cash Growth | -30.04% | -31.41% | -28.10% | 58.89% | 10.58% | 1713.83% | Upgrade
|
| Net Cash Per Share | 4.44 | 5.88 | 9.21 | 17.72 | 17.94 | 36.35 | Upgrade
|
| Filing Date Shares Outstanding | 1.54 | 1.54 | 1.52 | 1.34 | 0.87 | 0.63 | Upgrade
|
| Total Common Shares Outstanding | 1.54 | 1.54 | 1.52 | 1.34 | 0.87 | 0.61 | Upgrade
|
| Working Capital | 6.02 | 8.78 | 12.58 | 17.3 | 11.43 | 9.67 | Upgrade
|
| Book Value Per Share | 4.56 | 6.36 | 9.00 | 13.68 | 13.97 | 28.37 | Upgrade
|
| Tangible Book Value | 7.03 | 9.79 | 13.64 | 18.39 | 12.21 | 7.97 | Upgrade
|
| Tangible Book Value Per Share | 4.56 | 6.36 | 9.00 | 13.68 | 13.97 | 13.14 | Upgrade
|
| Machinery | - | - | - | - | - | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.